Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF — Stella

Home/Heart Failure With Preserved Ejection Fraction/Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF

View on ClinicalTrials.gov

Recruiting

Back to Heart Failure With Preserved Ejection Fraction trials

Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF

Trial locations(1 site)

Germany

Universitätsmedizin Göttingen, Göttingen, Lower Saxony

Key details

Sponsor

University Medical Center Goettingen

Enrollment target

~150 participants

Started

February 2024

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.